Schedule of Segment Reporting Information |
Segment Reporting as of and for the year
ended December 31, 2018
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
|
Segments Total |
|
|
Corporate (2) |
|
|
Consolidated Total |
|
Revenue from external customers |
|
$ |
36,271 |
|
|
$ |
13,268 |
|
|
|
— |
|
|
$ |
49,539 |
(3) |
|
$ |
— |
|
|
$ |
49,539 |
|
Intercompany revenues |
|
|
509 |
|
|
|
70 |
|
|
|
— |
|
|
|
579 |
|
|
|
— |
|
|
|
— |
|
Gross profit |
|
|
7,197 |
|
|
|
1,264 |
|
|
|
— |
|
|
|
8,461 |
|
|
|
— |
|
|
|
8,461 |
|
Research and development |
|
|
483 |
|
|
|
— |
|
|
|
811 |
|
|
|
1,294 |
|
|
|
76 |
|
|
|
1,370 |
|
Interest income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
295 |
|
|
|
295 |
|
Interest expense |
|
|
(22 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
(24 |
) |
|
|
(227 |
) |
|
|
(251 |
) |
Interest expense-financing fees |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(38 |
) |
|
|
(38 |
) |
Depreciation and amortization |
|
|
943 |
|
|
|
465 |
|
|
|
— |
|
|
|
1,408 |
|
|
|
47 |
|
|
|
1,455 |
|
Segment income (loss) before income taxes |
|
|
4,550 |
(6) |
|
|
(756 |
) |
|
|
(811 |
) |
|
|
2,983 |
|
|
|
(4,993 |
) |
|
|
(2,010 |
) |
Income tax (benefit) expense |
|
|
(943 |
)(7) |
|
|
— |
|
|
|
— |
|
|
|
(943 |
) |
|
|
7 |
|
|
|
(936 |
) |
Segment income (loss) |
|
|
5,493 |
|
|
|
(756 |
) |
|
|
(811 |
) |
|
|
3,926 |
|
|
|
(5,000 |
) |
|
|
(1,074 |
) |
Segment assets(1) |
|
|
32,800 |
|
|
|
5,188 |
|
|
|
25 |
|
|
|
38,013 |
|
|
|
19,429 |
(4) |
|
|
57,442 |
|
Expenditures for segment assets |
|
|
1,311 |
|
|
|
117 |
|
|
|
— |
|
|
|
1,428 |
|
|
|
4 |
|
|
|
1,432 |
|
Total debt |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,302 |
(5) |
|
|
3,302 |
|
Segment Reporting as of and for the year ended December 31, 2017
|
|
Treatment |
|
|
Services |
|
|
Medical |
|
|
Segments Total |
|
|
Corporate (2) |
|
|
Consolidated Total |
|
Revenue from external customers |
|
$ |
37,750 |
|
|
$ |
12,019 |
|
|
|
— |
|
|
$ |
49,769 |
(3) |
|
$ |
— |
|
|
$ |
49,769 |
|
Intercompany revenues |
|
|
362 |
|
|
|
31 |
|
|
|
— |
|
|
|
393 |
|
|
|
— |
|
|
|
— |
|
Gross profit |
|
|
7,916 |
|
|
|
704 |
|
|
|
— |
|
|
|
8,620 |
|
|
|
— |
|
|
|
8,620 |
|
Research and development |
|
|
439 |
|
|
|
— |
|
|
|
1,141 |
|
|
|
1,580 |
|
|
|
15 |
|
|
|
1,595 |
|
Interest income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
140 |
|
|
|
140 |
|
Interest expense |
|
|
(35 |
) |
|
|
(5 |
) |
|
|
— |
|
|
|
(40 |
) |
|
|
(275 |
) |
|
|
(315 |
) |
Interest expense-financing fees |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(35 |
) |
|
|
(35 |
) |
Depreciation and amortization |
|
|
3,228 |
|
|
|
536 |
|
|
|
— |
|
|
|
3,764 |
|
|
|
39 |
|
|
|
3,803 |
|
Segment income (loss) before income taxes |
|
|
3,577 |
(8) |
|
|
(2,286 |
) |
|
|
(1,141 |
) |
|
|
150 |
|
|
|
(4,973 |
) |
|
|
(4,823 |
) |
Income tax (benefit) expense |
|
|
(1,290 |
)(7) |
|
|
— |
|
|
|
— |
|
|
|
(1,290 |
) |
|
|
5 |
|
|
|
(1,285 |
) |
Segment income (loss) |
|
|
4,867 |
|
|
|
(2,286 |
) |
|
|
(1,141 |
) |
|
|
1,440 |
|
|
|
(4,978 |
) |
|
|
(3,538 |
) |
Segment assets(1) |
|
|
32,724 |
|
|
|
6,324 |
|
|
|
548 |
|
|
|
39,596 |
|
|
|
19,942 |
(4) |
|
|
59,538 |
|
Expenditures for segment assets |
|
|
396 |
|
|
|
43 |
|
|
|
— |
|
|
|
439 |
|
|
|
— |
|
|
|
439 |
|
Total debt |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,847 |
(5) |
|
|
3,847 |
|
|
(1) |
Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment. |
|
|
|
|
(2) |
Amounts reflect the activity for corporate headquarters not included in the segment information. |
|
(3) |
The Company performed services relating to waste generated by the domestic government clients (includes U.S federal, state and local), either directly as a prime contractor or indirectly for others as a subcontractor to government entities, representing approximately $34,811,000 or 70.3% of total revenue for 2018 and $37,019,000 or 74.4% of total revenue for 2017. The following reflects such revenue generated by our two segments: |
|
|
2018 |
|
|
2017 |
|
Treatment |
|
$ |
25,181,000 |
|
|
$ |
27,956,000 |
|
Services |
|
|
9,630,000 |
|
|
|
9,063,000 |
|
Total |
|
$ |
34,811,000 |
|
|
$ |
37,019,000 |
|
|
(4) |
Amount includes assets from our discontinued operations of $306,000 and $365,000 at December 31, 2018 and 2017, respectively. |
|
|
|
|
(5) |
Net of debt issuance costs of ($80,000) and ($115,000) for 2018 and 2017, respectively (see “Note 10 – “Long-Term Debt” for additional information). |
|
|
|
|
(6) |
Amount includes a net gain of $1,596,000 recorded resulting from the exchange offer of the Series B Preferred Stock of the Company’s M&EC subsidiary (see “Note 8 – Series B Preferred Stock”) |
|
|
|
|
(7) |
For the year ended December 31, 2018 and 2017, amount includes a tax benefit recorded in the amount of approximately $1,235,000 and $1,695,000, respectively, resulting from the TCJA enacted on December 22, 2017 (see “Note 14 – Income Taxes” for further information of this tax benefit). |
|
|
|
|
(8) |
Amount includes tangible asset impairment loss of $672,000 recorded in connection with the closure of M&EC (see “Note 4 – M&EC Facility”). |
|